Conversation with Diana Shineman of the Alzheimer's Drug Discovery Foundation
8 views
Skip to first unread message
Mike Danto
Sep 10, 2015, 3:25:29 PM9/10/15
to newly-published-g...@googlegroups.com, newly.p...@openphilanthropy.org
http://files.givewell.org/files/conversations/Diana_Shineman_06-08-15_(public).pdf
The Open Philanthropy Project spoke with Dr. Shineman of the Alzheimer’s Drug Discovery Foundation (ADDF) as part of its investigation into Alzheimer’s disease. Conversation topics included the ADDF’s research priorities, challenges and opportunities in the Alzheimer’s disease funding space, and the importance of biomarker development, as well as a number of other issues facing the field.
--
The Open Philanthropy Project spoke with Dr. Shineman of the Alzheimer’s Drug Discovery Foundation (ADDF) as part of its investigation into Alzheimer’s disease. Conversation topics included the ADDF’s research priorities, challenges and opportunities in the Alzheimer’s disease funding space, and the importance of biomarker development, as well as a number of other issues facing the field.
--
Reply all
Reply to author
Forward
0 new messages